Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Schnitt

Showing results (71-80 of 232) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysisElena B Elkin, Milton C Weinstein, Eric P Winer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2021
TDLU Involution and Breast Cancer Risk-ReplyYujing J Heng, Kevin H Kensler, Gabrielle M Baker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2017
Reply to RosenJorge S Reis-Filho, Felipe C Geyer, Britta Weigelt, et al.
Cancer Causes & Control : CCC|February 11, 2018
Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?Nancy Krieger, Sheida Nabavi, Pamela D Waterman, et al.
Cancer|September 21, 2004
Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinomaWendy Y Chen, Susan E Hankinson, Stuart J Schnitt, et al.
Cancer|November 14, 2015
Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health StudiesLaura C Collins, Sarah A Aroner, James L Connolly, et al.
Cancer|December 13, 2006
Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health StudyLaura C Collins, Heather J Baer, Rulla M Tamimi, et al.
Breast Cancer Research : BCR|August 10, 2010
Columnar cell lesions and subsequent breast cancer risk: a nested case-control studySarah A Aroner, Laura C Collins, Stuart J Schnitt, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinomaSarah A Thurman, Stuart J Schnitt, James L Connolly, et al.
Cancer|August 12, 2006
The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health StudyLaura C Collins, Heather J Baer, Rulla M Tamimi, et al.
Pageof 24

Showing results (71-80 of 232) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysisElena B Elkin, Milton C Weinstein, Eric P Winer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2021
TDLU Involution and Breast Cancer Risk-ReplyYujing J Heng, Kevin H Kensler, Gabrielle M Baker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2017
Reply to RosenJorge S Reis-Filho, Felipe C Geyer, Britta Weigelt, et al.
Cancer Causes & Control : CCC|February 11, 2018
Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?Nancy Krieger, Sheida Nabavi, Pamela D Waterman, et al.
Cancer|September 21, 2004
Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinomaWendy Y Chen, Susan E Hankinson, Stuart J Schnitt, et al.
Cancer|November 14, 2015
Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health StudiesLaura C Collins, Sarah A Aroner, James L Connolly, et al.
Cancer|December 13, 2006
Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health StudyLaura C Collins, Heather J Baer, Rulla M Tamimi, et al.
Breast Cancer Research : BCR|August 10, 2010
Columnar cell lesions and subsequent breast cancer risk: a nested case-control studySarah A Aroner, Laura C Collins, Stuart J Schnitt, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinomaSarah A Thurman, Stuart J Schnitt, James L Connolly, et al.
Cancer|August 12, 2006
The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health StudyLaura C Collins, Heather J Baer, Rulla M Tamimi, et al.
Pageof 24